Skip to main content

$0.003 -0.001

High

$0.00

Low

$0.00

Trades

1

Turnover

$54

Volume

21,427
30 June 2023 at 2:30pm
Register to track ADR and receive email alerts.

Adherium submits US FDA application for Hailie for Teva MDIs

StockBot

416,823 posts

ADR released this announcement to the ASX on 25 August 2022, 8:37. The announcement is not marked as price sensitive, and is 2 page(s) in length and 113.01kb in size.

You can view all announcements from ADR and see how they appear on a price chart on the announcements page.

At the date of this announcement, ADR was 0.200% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 406th as of the latest reported data (14 February 2023).

Other Recent Announcements from ADR
Application for quotation of securities - ADR 28 June 2023, 16:25
Change of Auditor 27 June 2023, 9:41
Notification of cessation of securities - ADR 11 May 2023, 13:49
Adherium submits US FDA application for Hailie for Teva MDIs 25 August 2022, 8:37
Adherium to present at Reach Markets webinar 16 August 2022, 8:57
Adherium Investor Update Presentation August 2022 8 August 2022, 9:58
Details of Company Address - Principal Administrative Office 5 August 2022, 14:28
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track ADR and receive email alerts.